Allergy Therapeutics Plc (AGY) Ord GBP0.01
1.00p
(8.40%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.00p
(8.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1.00p
(8.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
11.90p
12.00p
12.10p
£669.42 million
11.90p
10.00p
5.25p
n/a
0.00p (0.00%) Previous:
0.00p
512,779
n/a
150,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/06/2024 | 30/06/2023 |
|---|---|---|
| Revenue (£m) | 55.20 | 59.59 |
| Profit before tax (£m) | (39.17) | (41.77) |
| Adjusted EPS (p): | (1.07) | (6.43) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Allergy Therapeutics starts dosing peanut allergy vaccine candidate
27 March 2023 15:16
-
Chief Strategy Officer and Board appointments
30 January 2026 08:22
-
Result of Annual General Meeting
29 January 2026 14:13
-
Grant of Options under Long Term Incentive Scheme
28 January 2026 16:48
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.